🇺🇸 FDA
Patent

US 10624849

Targeted extracellular vesicles comprising membrane proteins with engineered glycosylation sites

granted A61KA61K31/713A61K47/46

Quick answer

US patent 10624849 (Targeted extracellular vesicles comprising membrane proteins with engineered glycosylation sites) held by Northwestern University expires Mon Apr 16 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Northwestern University
Grant date
Tue Apr 21 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 16 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
21
CPC classes
A61K, A61K31/713, A61K47/46, A61K9/0019, A61K9/1075